{"id":"https://genegraph.clinicalgenome.org/r/5fd82050-dbbb-41dd-bdf8-2c9aa2ff3034v1.0","type":"EvidenceStrengthAssertion","dc:description":"FUT8 was first reported in relation to autosomal recessive congenital disorder of glycosylation with defective fucosylation 1 in 2018 (Ng et al., PMID: 29304374). 8 variants (nonsense, frameshift, splice site, and missense) that have been reported in 7 probands in 2 publications (PMIDs: 29304374, 32049367) are included in this curation. The maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is known to be loss of function. This gene-disease relationship is also supported by an animal knockout model (PMID: 16236725) and a cell line knockout model (PMID: 27008861). Both models showed a lack of fucosylated N-glycans, which is also observed in affected patients. In summary, there is definitive evidence supporting the relationship between FUT8 and autosomal recessive congenital disorder of glycosylation with defective fucosylation 1. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/5fd82050-dbbb-41dd-bdf8-2c9aa2ff3034","GCISnapshot":"https://genegraph.clinicalgenome.org/r/a593a104-5904-461f-956b-ad1e154df921","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/a593a104-5904-461f-956b-ad1e154df921_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2024-05-15T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/a593a104-5904-461f-956b-ad1e154df921_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2024-05-15T18:23:47.426Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a593a104-5904-461f-956b-ad1e154df921_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bc45462d-14f2-4aac-afb6-35547ddef7c4_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/56a8e665-8fa2-498f-9e4d-07187ee3e500","type":"EvidenceLine","dc:description":"Reduced scoring due to consanguinity and only one functional study.","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/56a8e665-8fa2-498f-9e4d-07187ee3e500_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"MALDI-TOF showed loss of serum core fucosylated N-glycans.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/56a8e665-8fa2-498f-9e4d-07187ee3e500_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32049367","allele":{"id":"https://genegraph.clinicalgenome.org/r/1a96dc2f-33dc-4dbb-91ea-2c6688ed7d1d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371533.1(FUT8):c.716G>A (p.Arg239Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA390119427"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/bc45462d-14f2-4aac-afb6-35547ddef7c4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32049367","rdfs:label":"Ng CDG-0096","allele":{"id":"https://genegraph.clinicalgenome.org/r/1a96dc2f-33dc-4dbb-91ea-2c6688ed7d1d"},"detectionMethod":"WES","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000821","obo:HP_0001249","obo:HP_0002783","obo:HP_0004322","obo:HP_0000252","obo:HP_0001508","obo:HP_0001252","obo:HP_0011968","obo:HP_0000377","obo:HP_0000787","obo:HP_0011344","obo:HP_0002119","obo:HP_0001250"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/56a8e665-8fa2-498f-9e4d-07187ee3e500_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ea73109d-301f-4056-b0ea-615d4d437c39_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0e94c656-049d-422c-ae35-df89e781958e","type":"EvidenceLine","dc:description":"Did not downgrade for consanguinity since multiple functional studies performed.","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0e94c656-049d-422c-ae35-df89e781958e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"WB revealed no detectable FUT8 protein in patient fibroblasts. LC-MS on serum glycans showed complete loss of total core fucosylated N-glycans compared to controls (N = 2). LC-MS on fibroblasts showed complete loss of core fucosylated N-glycans as compared to healthy unaffected controls (N = 3). FACS on patient fibroblasts displayed profound deficiencies in LcH and PSA lectin reactivity.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/0e94c656-049d-422c-ae35-df89e781958e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29304374","allele":{"id":"https://genegraph.clinicalgenome.org/r/cd133434-0f9f-4c1b-ad61-8ce887a57924","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371533.1(FUT8):c.715C>T (p.Arg239Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA390119426"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/ea73109d-301f-4056-b0ea-615d4d437c39","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29304374","rdfs:label":"Ng CDG-0448","allele":{"id":"https://genegraph.clinicalgenome.org/r/cd133434-0f9f-4c1b-ad61-8ce887a57924"},"detectionMethod":"Trio sequencing","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000431","obo:HP_0002098","obo:HP_0001561","obo:HP_0001631","obo:HP_0011968","obo:HP_0000252","obo:HP_0000821","obo:HP_0001643","obo:HP_0001195","obo:HP_0001252","obo:HP_0001250","obo:HP_0000121","obo:HP_0001249","obo:HP_0009826","obo:HP_0000218","obo:HP_0011344","obo:HP_0001508","obo:HP_0000278","obo:HP_0004322","obo:HP_0001875","obo:HP_0001511"],"previousTesting":true,"previousTestingDescription":"All biochemical and molecular testing normal. Chromosomal microarray showed large regions of homozygosity consistent with consanguineous parents.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/0e94c656-049d-422c-ae35-df89e781958e_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/42d0d517-e842-4079-a2a5-c5db359c1876_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c0a06f44-9b20-4285-9d27-07f6072805c0","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c0a06f44-9b20-4285-9d27-07f6072805c0_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"WB revealed no detectable FUT8 protein in patient fibroblasts. RNA studies (cDNA seq) showed two transcripts - wt and a shorter one. Sanger seq confirmed the short transcript contained an inframe deletion of exon 9. Based on crystal structure analysis, this should affect several critical residues (His363, which recognizes the guanine of GDP-fucose, and Arg365, which recognizes both the Î²-phosphate of GDP-fucose and the fucose moiety itself, would be deleted.) LC-MS on serum glycans showed complete loss of total core fucosylated N-glycans compared to controls (N = 2). LC-MS on patient fibroblasts showed complete loss of core fucosylated N-glycans as compared to healthy unaffected controls (N = 3). FACS on patient fibroblasts displayed profound deficiencies in LcH and PSA lectin reactivity.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/c0a06f44-9b20-4285-9d27-07f6072805c0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29304374","allele":{"id":"https://genegraph.clinicalgenome.org/r/db0b2ac9-a31d-43d1-a823-026bfbfecdee","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371533.1(FUT8):c.1259+5G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA658824634"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/bb673099-853a-4a7d-a3e7-2539a9b94209","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bb673099-853a-4a7d-a3e7-2539a9b94209_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"WB revealed no detectable FUT8 protein in patient fibroblasts. LC-MS on serum glycans showed complete loss of total core fucosylated N-glycans compared to controls (N = 2). LC-MS on patient fibroblasts showed complete loss of core fucosylated N-glycans as compared to healthy unaffected controls (N = 3). FACS on patient fibroblasts displayed profound deficiencies in LcH and PSA lectin reactivity.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/bb673099-853a-4a7d-a3e7-2539a9b94209_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29304374","allele":{"id":"https://genegraph.clinicalgenome.org/r/d1636ce7-c096-4cfd-b419-f88ed103fda6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371533.1(FUT8):c.1009C>G (p.Arg337Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA390245370"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/42d0d517-e842-4079-a2a5-c5db359c1876","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29304374","rdfs:label":"Ng CDG-0459","allele":[{"id":"https://genegraph.clinicalgenome.org/r/db0b2ac9-a31d-43d1-a823-026bfbfecdee"},{"id":"https://genegraph.clinicalgenome.org/r/d1636ce7-c096-4cfd-b419-f88ed103fda6"}],"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002878","obo:HP_0000337","obo:HP_0001249","obo:HP_0011968","obo:HP_0001511","obo:HP_0001561","obo:HP_0002099","obo:HP_0001252","obo:HP_0009826","obo:HP_0001250","obo:HP_0004322","obo:HP_0001943","obo:HP_0011344","obo:HP_0000348","obo:HP_0000252","obo:HP_0000557","obo:HP_0000501"],"previousTesting":false,"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/bb673099-853a-4a7d-a3e7-2539a9b94209_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/c0a06f44-9b20-4285-9d27-07f6072805c0_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/34986a22-0de6-44f1-aa63-ed7e0ad21b3d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9e060d1c-e5ca-4627-8fcf-38a8f3af8aa3","type":"EvidenceLine","dc:description":"Subtracted 0.5 pts for consanguinity and only one functional study performed.","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9e060d1c-e5ca-4627-8fcf-38a8f3af8aa3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"MALDI-TOF showed loss of serum core fucosylated N-glycans","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/9e060d1c-e5ca-4627-8fcf-38a8f3af8aa3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32049367","allele":{"id":"https://genegraph.clinicalgenome.org/r/5e68d92c-b94c-4585-a771-352341c3e2cf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371533.1(FUT8):c.1302G>A (p.Trp434Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA390249214"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/34986a22-0de6-44f1-aa63-ed7e0ad21b3d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32049367","rdfs:label":"Ng CDG-0095","allele":{"id":"https://genegraph.clinicalgenome.org/r/5e68d92c-b94c-4585-a771-352341c3e2cf"},"detectionMethod":"WES","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000278","obo:HP_0004322","obo:HP_0001508","obo:HP_0001252","obo:HP_0011344","obo:HP_0011968","obo:HP_0001249","obo:HP_0002783","obo:HP_0000252","obo:HP_0000431","obo:HP_0001528","obo:HP_0001250","obo:HP_0001561"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/9e060d1c-e5ca-4627-8fcf-38a8f3af8aa3_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/27a81cdc-cdb4-4959-a8f3-879cce2ebcba_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/082d74aa-c07e-4d78-9e9e-fb15f1508b86","type":"EvidenceLine","dc:description":"Downgraded for consanguinity since only one functional study was performed.","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/082d74aa-c07e-4d78-9e9e-fb15f1508b86_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"LC-MS on serum glycans showed complete loss of total core fucosylated N-glycans compared to controls (N = 2).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/082d74aa-c07e-4d78-9e9e-fb15f1508b86_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29304374","allele":{"id":"https://genegraph.clinicalgenome.org/r/52a33d7b-f5da-4ffe-b70c-ade3e2336066","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371533.1(FUT8):c.943C>T (p.Arg315Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA390244424"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/27a81cdc-cdb4-4959-a8f3-879cce2ebcba","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29304374","rdfs:label":"Ng CDG-0464","ageType":"AgeAtDeath","ageUnit":"Years","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/52a33d7b-f5da-4ffe-b70c-ade3e2336066"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000577","obo:HP_0002751","obo:HP_0011344","obo:HP_0003196","obo:HP_0001007","obo:HP_0001252","obo:HP_0001508","obo:HP_0000485","obo:HP_0034392","obo:HP_0004322","obo:HP_0000938","obo:HP_0000520","obo:HP_0002783","obo:HP_0000341","obo:HP_0001249","obo:HP_0001250","obo:HP_0000252","obo:HP_0002827","obo:HP_0011968"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/082d74aa-c07e-4d78-9e9e-fb15f1508b86_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/dbebac02-7d3c-446f-a9bf-37ddfaedad6c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/61330835-b570-4331-a6a5-7f9a8bf822e0","type":"EvidenceLine","dc:description":"Reduced score for consanguinity with minimal testing and because variant is in the last exon and is predicted to be NMD-.","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/61330835-b570-4331-a6a5-7f9a8bf822e0_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"MALDI-TOF showed loss of serum core fucosylated N-glycans","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/61330835-b570-4331-a6a5-7f9a8bf822e0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32049367","allele":{"id":"https://genegraph.clinicalgenome.org/r/a3775059-1dc3-4dbf-b259-2ce622944917","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371533.1(FUT8):c.1675C>T (p.Arg559Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7233493"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/dbebac02-7d3c-446f-a9bf-37ddfaedad6c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32049367","rdfs:label":"Ng CDG-0108","allele":{"id":"https://genegraph.clinicalgenome.org/r/a3775059-1dc3-4dbf-b259-2ce622944917"},"detectionMethod":"WES","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0011003","obo:HP_0000252","obo:HP_0011968","obo:HP_0001252","obo:HP_0001249","obo:HP_0005280","obo:HP_0002827","obo:HP_0004322","obo:HP_0100704","obo:HP_0006528","obo:HP_0011344","obo:HP_0002650","obo:HP_0034392","obo:HP_0001508","obo:HP_0001250"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/61330835-b570-4331-a6a5-7f9a8bf822e0_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/0dfc2769-e06b-4d88-aa22-a194959aaa41_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5689b8f8-3328-4567-911f-7a7088a3a817","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5689b8f8-3328-4567-911f-7a7088a3a817_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32049367","allele":{"id":"https://genegraph.clinicalgenome.org/r/9cbec722-8912-48bb-b735-b61dc8d6cb37","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001371533.1(FUT8):c.1402del (p.Ser468HisfsTer26)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2625300705"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/0dfc2769-e06b-4d88-aa22-a194959aaa41","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32049367","rdfs:label":"Ng CDG-0099","allele":{"id":"https://genegraph.clinicalgenome.org/r/9cbec722-8912-48bb-b735-b61dc8d6cb37"},"detectionMethod":"Trio WES","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002783","obo:HP_0011344","obo:HP_0011968","obo:HP_0001252","obo:HP_0000501","obo:HP_0001508","obo:HP_0001511","obo:HP_0000280","obo:HP_0002650","obo:HP_0001250","obo:HP_0000494","obo:HP_0000218","obo:HP_0001249","obo:HP_0000252","obo:HP_0004322"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/5689b8f8-3328-4567-911f-7a7088a3a817_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/a593a104-5904-461f-956b-ad1e154df921_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a593a104-5904-461f-956b-ad1e154df921_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7f191430-c492-4fc5-9631-661dc226ac55","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c9a25e64-05d0-40d6-a4c5-f50ef8cc3402","type":"Finding","dc:description":"Knockout mice exhibited an absence of fucosylated N-glycans, which is also seen in humans. These mice also exhibited early death and smaller size.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16236725","rdfs:label":"Wang Knockout Mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a593a104-5904-461f-956b-ad1e154df921_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/466c4dfe-96c7-4dc0-be3e-24583cc1a545","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ad414427-54d0-4cac-ba02-79a812112ab7","type":"Finding","dc:description":"Patients with pathogenic FUT8 mutations have low to no fucosylated glycoforms in their serum.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27008861","rdfs:label":"Yang HEK293S Cell Knockout","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5}],"evidenceStrength":"Definitive","sequence":8301,"specifiedBy":"GeneValidityCriteria10","strengthScore":14.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/iKG_fQLTEQk","type":"GeneValidityProposition","disease":"obo:MONDO_0020775","gene":"hgnc:4019","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_a593a104-5904-461f-956b-ad1e154df921-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}